LukeMilburnJudgeMDPhD

Neonatal Respiratory Failure & Lung Development

Associate Professor of Pediatrics

Dr. Judge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1855 4th St
San Francisco, CA 94143
Phone+1 800-793-3887

Fax+1 415-502-0660

University of California (San Francisco)Fellowship, Neonatal-Perinatal Medicine, 2011 - 2014
University of California (San Francisco)Residency, Pediatrics, 2008 - 2011
University of Washington School of MedicineClass of 2008

PubMed

Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in.
Poorvi H Dua, Bazilco M J Simon, Chiara B E Marley, Carissa M Feliciano, Hannah L Watry
Biorxiv. 2024-12-22
3 citations
Neuronal DNA repair reveals strategies to influence CRISPR editing outcomes.
Gokul N Ramadoss, Samali J Namaganda, Jennifer R Hamilton, Rohit Sharma, Karena G Chow
Biorxiv. 2024-06-26
4 citations
Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.
Jonas Van Lent, Robert Prior, Gonzalo Pérez Siles, Anthony N Cutrupi, Marina L Kennerson
Experimental & Molecular Medicine. 2024-06-01

Journal Articles

Two Patients with FOXF1 Mutations with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins and Other Malformations: Two Different Presentations and Outcomes
Luke M Judge, Jeff Fineman, Anne M Slavotinek, American Journal of Medical Genetics Part A

Allele-specific inactivation for dominant negative NEFL MutationsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2021–2026